Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Amsurg Corp (AMSG)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Amsurg Corp.
Table 2 shows the detailed insider transactions.
This company's CIK number is 895930.
Total stock buying since 2014: $0.
Total stock sales since 2014: $10,755,419.
Total stock option exercises since 2014: $1,298,356.
Table 3. Detailed insider trading at Amsurg Corp (AMSG)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2016-12-01 | Coward Robert Jon (Executive Vice President) | Option Ex | 9,232 | .00 | 0 |
| 2016-12-01 | Clendenin Phillip A (President Ambulatory Services) | Option Ex | 5,018 | .00 | 0 |
| 2016-12-01 | Eastridge Kevin Delon (Sr. VP of Finance, CAO) | Option Ex | 3,497 | .00 | 0 |
| 2016-12-01 | Gulmi Claire M (Executive VP & CFO) | Option Ex | 5,731 | .00 | 0 |
| 2016-12-01 | Holden Christopher A (President and CEO) | Option Ex | 32,441 | .00 | 0 |
| 2016-08-26 | Coward Robert Jon (Executive Vice President) | Sale | 7,500 | 63.65 | 477,375 |
| 2016-08-18 | Coward Robert Jon (Executive Vice President) | Sale | 7,500 | 64.36 | 482,700 |
| 2015-09-02 | Holden Christopher A (President and CEO) | Sale | 3,000 | 77.00 | 231,012 |
| 2015-08-14 | Gulmi Claire M (Executive VP & CFO) | Sale | 15,000 | 84.74 | 1,271,085 |
| 2015-08-10 | Coward Robert Jon (Executive Vice President) | Sale | 24,700 | 83.28 | 2,057,065 |
| 2015-08-07 | Coward Robert Jon (Executive Vice President) | Sale | 5,300 | 83.17 | 440,801 |
| 2015-08-03 | Holden Christopher A (President and CEO) | Sale | 3,000 | 71.67 | 215,010 |
| 2015-07-01 | Holden Christopher A (President and CEO) | Sale | 3,000 | 70.24 | 210,726 |
| 2015-06-03 | Holden Christopher A (President and CEO) | Sale | 3,000 | 69.02 | 207,054 |
| 2015-05-05 | Holden Christopher A (President and CEO) | Sale | 3,000 | 62.91 | 188,739 |
| 2015-04-06 | Holden Christopher A (President and CEO) | Sale | 3,000 | 63.36 | 190,086 |
| 2015-03-26 | Lavender Kevin P (Director) | Sale | 2,500 | 62.00 | 154,992 |
| 2015-03-24 | Gulmi Claire M (Executive VP & CFO) | Sale | 24,008 | 64.18 | 1,540,737 |
| 2015-03-24 | Gulmi Claire M (Executive VP & CFO) | Option Ex | 24,008 | 24.75 | 594,198 |
| 2015-03-19 | Clendenin Phillip A (President Ambulatory Services) | Sale | 9,598 | 62.88 | 603,551 |
| 2015-03-04 | Eastridge Kevin Delon (Sr. VP of Finance, CAO) | Sale | 8,999 | 60.43 | 543,809 |
| 2014-12-05 | Manning David L (EVP-Chief Development Officer) | Sale | 5,000 | 50.83 | 254,155 |
| 2014-12-05 | Manning David L (EVP-Chief Development Officer) | Option Ex | 5,000 | 21.07 | 105,350 |
| 2014-11-28 | Manning David L (EVP-Chief Development Officer) | Sale | 5,000 | 51.68 | 258,400 |
| 2014-11-28 | Manning David L (EVP-Chief Development Officer) | Option Ex | 5,000 | 21.07 | 105,350 |
| 2014-11-26 | Lavender Kevin P (Director) | Sale | 3,000 | 51.51 | 154,530 |
| 2014-11-20 | Manning David L (EVP-Chief Development Officer) | Sale | 4,956 | 50.63 | 250,907 |
| 2014-11-20 | Manning David L (EVP-Chief Development Officer) | Option Ex | 4,956 | 21.07 | 104,422 |
| 2014-11-18 | Manning David L (EVP-Chief Development Officer) | Sale | 5,044 | 50.60 | 255,221 |
| 2014-11-18 | Manning David L (EVP-Chief Development Officer) | Option Ex | 5,044 | 21.07 | 106,277 |
| 2014-06-09 | Manning David L (EVP-Chief Development Officer) | Sale | 12,380 | 50.75 | 628,285 |
| 2014-06-09 | Manning David L (EVP-Chief Development Officer) | Option Ex | 12,380 | 22.84 | 282,759 |
| 2014-06-03 | Holden Christopher A (President and CEO) | Sale | 3,000 | 46.39 | 139,179 |
Insider trading activities including stock purchases, stock sales, and option exercises
of AMSG listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Amsurg Corp (symbol AMSG,
CIK number 895930) see
the Securities and Exchange Commission (SEC) website.